To show the superiority of epinastine @ % ophthalmic solution ( epinastine ) to placebo ophthalmic solution ( placebo ) and noninferiority to olopatadine @ % ophthalmic solution ( olopatadine ) for cedar pollen antigen-induced ocular itching and conjunctival hyperemia .